• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH HI-TEC, INC. AIA-360; FLUOROMETER, FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH HI-TEC, INC. AIA-360; FLUOROMETER, FOR CLINICAL USE Back to Search Results
Model Number AIA-360 IMMUNOASSAY ANALYZER
Device Problem High Readings (2459)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/10/2024
Event Type  malfunction  
Manufacturer Narrative
The technical support specialist (tss) addressed the reported event over the phone with the customer.The customer performed run with the received mac controls, but the results were still high.The tss instructed the customer to recalibrate the analyzer, which resolved the issue.The aia-360 analyzer is functioning as expected after recalibration.No further action required.A 13-month complaint history review and service history review through aware date of event for similar complaints was performed for serial number (b)(6) and estradiol test cup lot d712902.There were no other similar complaints found during the searched period.The estradiol (e2) st aia-pack analyte application manual states the following: quality control: in order to monitor and evaluate the precision of the analytical performance, it is recommended that commercially available control samples be assayed daily.The minimum recommendations for the frequency of running internal control material are: ¿ after calibration, two levels of controls are run in order to accept the calibration curve.¿ the two levels of controls are also repeated after calibration when certain service procedures are performed (e.G.Temperature adjustment, sampling mechanism changes, maintenance of the wash probe or detector lamp adjustment or change).¿ after daily maintenance, at least two levels of the control should be run in order to verify the overall performance of the tosoh aia system analyzers.If one or more control sample value(s) is out of the acceptable range, it will be necessary to investigate the validity of the calibration curve before reporting patient results.Standard laboratory procedures should be followed in accordance with the regulatory agency under which the laboratory operates.Limitations of the procedure: for diagnostic purposes, the results obtained from this assay should be used in conjunction with other data (e.G.Symptoms, results of other tests, clinical impressions, therapy, etc.).Using st aia-pack e2, the highest concentration of estradiol measurable without dilution is approximately 3000 pg/ml, and the lowest measurable concentration is 25 pg/ml (assay sensitivity).Although the approximate value of the highest calibrator is 3250 pg/ml, the exact concentration may be slightly different.The assay specification, assay range high, should be defined as the upper limit of the assay range, 3000 pg/ml.Although hemolysis has an insignificant effect on the assay, hemolyzed samples may indicate mistreatment of a specimen prior to assay and results should be interpreted with caution.Lipemia has an insignificant effect on the assay except in the case of gross lipemia where spatial interference may occur.Specimens from patients with hyperbilirubinemia may yield falsely elevated results.Certain medications may interfere with assay performance.Specimens from patients taking medicines and/or medical treatment may show erroneous results.All results should be interpreted with respect to the clinical picture of the patient.For a more complete understanding of the limitations of this procedure, please refer to the specimen collection and handling, warnings and precautions, storage and stability, and procedural notes sections in this insert sheet.The most probable cause could not be established.
 
Event Description
A customer reported quality control out of range high for estradiol (e2) lot d712902 using biorad 40431 on the aia-360 analyzer.The customer stated the out of range shift started after changing to a new lot.The technical support specialist sent mac controls and calibrators to the customer to further troubleshoot which caused a delay in reporting of patient samples for estradiol (e2).There is no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIA-360
Type of Device
FLUOROMETER, FOR CLINICAL USE
Manufacturer (Section D)
TOSOH HI-TEC, INC.
1-37, fukugawa minami-machi
shunan, yamaguchi 74600 42
JA  7460042
Manufacturer (Section G)
TOSOH HI-TEC, INC.
1-37, fukugawa minami-machi
shunan, yamaguchi 74600 42
JA   7460042
Manufacturer Contact
jorge porras
shiba-koen first building
3-8-2 shiba
minato-ku 10586-23
JA   1058623
6506368314
MDR Report Key18637666
MDR Text Key335199278
Report Number3004529019-2024-00507
Device Sequence Number1
Product Code KHO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K971103
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAIA-360 IMMUNOASSAY ANALYZER
Device Catalogue Number019945
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/10/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/01/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-